SCHEMBL19917469

SCHEMBL19917469

OC(O)c1cc(F)c(Br)cc1F

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CES2 O00748 1/20 0.36
CES1 P23141 1/20 0.36
KDM1A O60341 2/20 0.35
KCNH2 Q12809 2/20 0.35
KDM1B Q8NB78 1/20 0.35
ADRB2 P07550 1/20 0.33
CYP3A4 P08684 1/20 0.33
HSD17B10 Q99714 1/20 0.33
ADRA2A P08913 1/20 0.33
ADRA2B P18089 1/20 0.33
ADRA2C P18825 1/20 0.33
ADRA1A P35348 1/20 0.33
KDM4E B2RXH2 1/20 0.32
MAPT P10636 1/20 0.32
APEX1 P27695 1/20 0.32
RAD52 P43351 1/20 0.32
RECQL P46063 1/20 0.32
BLM P54132 1/20 0.32
NPSR1 Q6W5P4 1/20 0.32
KDM4C Q9H3R0 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23129205 0.83 ADRB2 (0.30) ADRB2CYP3A4HSD17B10ADRA2AADRA2B
SCHEMBL23095908 0.82 PDE2A (0.35) CES2CES1KDM1AKCNH2KDM1B
SCHEMBL29556268 0.80 KDM1A (0.38) CES2CES1KDM1AKCNH2KDM1B
SCHEMBL16035329 0.80 KDM1A (0.38) CES2CES1KDM1AKCNH2KDM1B
SCHEMBL12744995 0.78 KDM1A (0.36) KDM1AKCNH2KDM1B
SCHEMBL12413927 0.76 GABRA1 (0.38) KDM1AKCNH2KDM1BADRB2RECQL
SCHEMBL505780 0.76 KDM1A (0.48) KDM1AKCNH2KDM1BCYP3A4KDM4E
SCHEMBL19192322 0.73 PDE2A (0.44) KDM1AKCNH2KDM1BIDH1
SCHEMBL16044371 0.73 PDE2A (0.44) KDM1AKCNH2KDM1BIDH1
SCHEMBL19151612 0.71 ADRB2 (0.38) ADRB2CYP3A4HSD17B10ADRA2AADRA2B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2018039386-A1 HORMONE RECEPTOR MODULATORS FOR TREATING METABOLIC CONDITIONS AND DISORDERS ARDELYX, INC. (US) 2018-03-01 WO disclosed